临床试验

HistoSonics用于治疗原发性实体肾肿瘤的研究性系统

NCT：NCT05432232 · COMPLETED

NCT编号NCT05432232

状态COMPLETED

开始日期2023-03-23

完成时间2025-06-06

SponsorHistoSonics, Inc. (INDUSTRY)

First posted2022-06-27

Last updated2026-09-11

简要摘要

The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。